Coronary revascularisation in chronic kidney disease. Part 1: stable coronary artery disease.
Chronic kidney disease (CKD) is associated with a high burden of coronary artery disease, myocardial infarction and cardiovascular death. Detection and treatment of coronary artery disease in CKD patients has been hampered by the limitations of screening tests, the lack of direct evidence for therapeutic interventions in this specific population, and concerns about therapy-related adverse effects. However, these patients potentially have much to gain from conventional strategies used in the general population. This review summarises the current evidence regarding the treatment of coronary artery disease in patients with CKD, with the focus on coronary revascularisation by percutaneous coronary intervention or coronary artery bypass grafting.
Seddon
Mike
M
Wessex Cardiac Unit, Southampton University Hospitals NHS Trust, Tremona Road, Southampton, SO16 6YD, UK.
Curzen
Nick
N
D015906:Angioplasty, Balloon, Coronary / Q000451:nursing*; D002318:Cardiovascular Diseases / Q000401:mortality / Q000451:nursing / Q000503:physiopathology; D002423:Cause of Death; D001026:Coronary Artery Bypass / Q000451:nursing*; D003327:Coronary Disease / Q000401:mortality / Q000451:nursing* / Q000503:physiopathology / Q000628:therapy*; D023903:Coronary Restenosis / Q000401:mortality / Q000451:nursing / Q000503:physiopathology / Q000628:therapy; D005919:Glomerular Filtration Rate / Q000502:physiology; D006801:Humans; D007676:Kidney Failure, Chronic / Q000401:mortality / Q000451:nursing* / Q000503:physiopathology*; D015607:Stents; D015996:Survival Rate; D016896:Treatment Outcome